COST
COST · US
COST Research Preview
| Metric | Reading |
|---|---|
| Price | 951.58 |
| Daily move | +1.77% |
| Overall score | 40/100 (Hold) |
| Trend | Bear |
| RSI14 / RSI6 | 36.12 / 31.00 |
| MACD (line/signal/hist) | -15.36 / -13.87 / -1.49 |
| Support (est.) | 912.97 (+4.06% away) |
| Resistance (est.) | 991.50 (+4.19% away) |
| 30-session range position | +42.34% (907.21-1012.00) |
| Data confidence | Medium |
| Indicator | Reading | Signal read |
|---|---|---|
| MA (5/10/20/60) | 936.02 / 939.11 / 952.24 / 987.86 | Bearish alignment (MA5<MA10<MA20<MA60); price -0.07% vs MA20 |
| RSI (14/6) | 36.12 / 31.00 | Soft but not washed out; not yet oversold-extreme |
| MACD (line/signal/hist) | -15.36 / -13.87 / -1.49 | Bearish; line below signal and below zero, momentum still fading |
| KDJ (K/D/J) | 29.77 / 35.97 / 17.37 | Soft / still repairing at low end |
| Bollinger (U/M/L) | 991.50 / 952.24 / 912.97 | Mid-band zone (49% of band); band width expanding |
| ATR14 (abs / %) | 20.21 / +2.21% | Moderate volatility relative to price |
| OBV / 20-session slope | -2,045,759.79 / -131.15% | Distribution pressure visible |
| CCI20 | -186.67 | Downside pressure / oversold territory |
Confirmed: the trend-following block agrees on a bear stance. MA alignment, MACD (below zero, negative histogram), OBV distribution, and CCI all point the same direction.
Conflicted: the mean-reversion block leans the other way. RSI14 (36.12), KDJ repairing off lows, CCI oversold, and proximity to the Bollinger lower band all suggest bounce potential, which is what the strategy score flags via RSI (60/100 Buy) and Bollinger (65/100 Buy). Net effect is a stalemate the model resolves as Hold.
Missing: no custom indicators were supplied, so none are folded in here. Volume context is thin on the confirming side - current volume is -21.83% versus the 20-session average of 2,689,216, and the strategy notes "price up on shrinking volume, insufficient upside strength" (量价关系 55/100 Hold), which weakens conviction in today's up move.
| Axis | Reading | Source | Confidence |
|---|---|---|---|
| PE | 52.26 | SEC EDGAR companyfacts | Medium |
| PB | 12.63 | SEC EDGAR companyfacts | Medium |
| Price / sales | 1.54 | SEC EDGAR companyfacts | Medium |
| EV/EBITDA | 32.01 | SEC EDGAR companyfacts | Low |
| PEG proxy | 4.55 | StockKit scenario model | Medium |
| StockKit fair value range | Bear $302.77 / Base $387.89 / Bull $492.20 | StockKit DCF scenario model | Medium |
| Base fair-value gap | -59.2% | StockKit DCF scenario model | Medium |
| 5Y growth forecast | Bear +5.49% / Base +11.49% / Bull +17.49% | StockKit scenario model | Medium |
| Revenue | $275.24B | SEC EDGAR companyfacts | High |
| Net income | $8.10B | SEC EDGAR companyfacts | High |
| Market cap | $423.27B | SEC shares outstanding + live quote | Medium |
| Balance sheet context | Assets $86.43B / Equity $33.51B | SEC EDGAR companyfacts | High |
The PEG proxy (4.55), fair-value range, base fair-value gap, and 5Y growth bands are StockKit internally computed scenario outputs, not analyst consensus targets. On those internal figures, the current price sits well above the Base fair-value estimate (a -59.2% gap), consistent with premium multiples (PE 52.26, PB 12.63, EV/EBITDA 32.01). The EV/EBITDA row is Low confidence and should be weighted accordingly. Revenue, net income, and balance-sheet items are High confidence and anchored to the 2025-08-31 annual period.
Confirmed headlines (source-supplied, 2026-08-03):
| Date | Headline | Source | Relevance to COST |
|---|---|---|---|
| 2026-08-03 | Israel's Supreme Court looks the other way as patients in Gaza suffer | Haaretz | No direct Costco linkage |
| 2026-08-03 | Lekuo Turns a Single PCIe Slot Into 12 Ports Using an AMD B650 Chip | Wccftech | No direct Costco linkage |
| 2026-08-03 | Which Is the Better State Street Healthcare ETF: XLV or XBI? | Biztoc.com | No direct Costco linkage |
| 2026-08-03 | What Makes Veeva Systems (VEEV) the Picks and Shovels of Drug Development? | Yahoo Entertainment | No direct Costco linkage |
Why this matters: none of the four available headlines reference Costco, its operations, membership, earnings, or guidance. There is no confirmed company-specific catalyst in the supplied feed.
Missing data: no Costco-specific news, earnings date, guidance update, or corporate action was supplied. This section is therefore low confidence, and the technical/valuation views should not be read as reacting to any known event.
| Source | Status | Reading | Confidence |
|---|---|---|---|
| NewsAPI headline coverage | 4 headlines | Haaretz x1, Wccftech x1, Biztoc.com x1 | Medium |
| Social sentiment | Not connected | No social sentiment conclusion is drawn | Low |
No provider-level sentiment score was supplied for this symbol, and no social feed (Reddit, X, StockTwits, or local forums) is marked connected, so none is reported. Headline coverage exists but, as noted above, is not Costco-specific, so it carries limited signal. Overall sentiment read is low confidence.
| Scenario | Trigger condition | What would confirm it | What would invalidate it |
|---|---|---|---|
| Base | Price oscillates around the MA20 / mid-band cluster (952.24) within the 30-session range (907.21-1012.00) | Score holds near 40/100 Hold; RSI stays soft (~36) without breakdown; OBV slope stabilizes | Decisive close and hold above 991.50 resistance, or sustained close below 912.97 support |
| Upside | Reclaim of MA20 (952.24) on improving volume toward the 20-session average (2,689,216) | Move toward resistance 991.50 (+4.19%), RSI (60/100 Buy) and Bollinger (65/100 Buy) mean-reversion signals gain traction, MACD histogram narrows | MACD stays firmly below zero, OBV distribution deepens, price rejected at MA20 |
| Downside | Loss of estimated support 912.97 (-4.06%) | Break of lower Bollinger band, CCI stays below -100/-186, bearish MA alignment steepens, OBV slope extends negative | Reclaim of MA20 and a positive MACD histogram cross |
| Risk | Evidence | Trigger | Monitoring action |
|---|---|---|---|
| Trend continuation lower | Bearish MA alignment; MACD below zero (-15.36); trend tagged bear | Close below support 912.97 | Track daily close vs 912.97 and lower Bollinger band |
| Weak-participation bounce | Volume -21.83% vs 20-session avg; "price up, volume down" note | Rallies stall on light volume near 952.24 | Compare daily volume against 2,689,216 average |
| Distribution pressure | OBV at -2.05M, 20-session slope -131.15% | OBV makes new lows while price stalls | Watch OBV slope for stabilization or further decline |
| Valuation premium | PE 52.26, PB 12.63, EV/EBITDA 32.01; Base fair-value gap -59.2% (StockKit model) | Any negative fundamental surprise | Monitor for supplied fundamental updates; treat model gap as internal, not consensus |
| Catalyst / sentiment blind spot | No Costco-specific news; social feed not connected | Unpriced company event | Re-check feeds; do not infer sentiment from unrelated headlines |
| Volatility | ATR14 at 20.21 (+2.21% of price); band width expanding | Range expansion around watch levels | Size expectations to ~2.2% daily true range |
1. MA20 / mid-band at 952.24 - the pivot; watch for a hold above vs rejection (price currently -0.07%). 2. Estimated support 912.97 (+4.06% away) - the key downside watch level; monitor daily closes. 3. Estimated resistance 991.50 (+4.19% away) - upside cap; needs volume to challenge. 4. Volume vs the 20-session average of 2,689,216 - confirm whether any rally has real participation (currently -21.83%). 5. MACD histogram (-1.49) - watch for narrowing/turn toward a zero-axis cross as an early momentum shift. 6. RSI14 (36.12) and CCI20 (-186.67) - watch for a repair off soft/oversold levels or a fresh breakdown. 7. OBV slope (-131.15%) - watch for stabilization; continued new lows signal deeper distribution.
MA5<MA20死叉，空头排列
MACD死叉，MACD在零轴下方，动能减弱
RSI14=36偏低
接近下轨，可能反弹，带宽扩张中
价涨量缩，上涨力度不足
Israel's Supreme Court looks the other way as patients in Gaza suffer
Haaretz · 2026-08-03
Lekuo Turns a Single PCIe Slot Into 12 Ports Using an AMD B650 Chip, No Bifurcation Needed
Wccftech · 2026-08-03
Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?
Biztoc.com · 2026-08-03
What Makes Veeva Systems (VEEV) the Picks and Shovels of Drug Development?
Yahoo Entertainment · 2026-08-03
Research boundary
StockKit organizes market data and model output for research workflows. It does not provide personalized advice or trade instructions. Verify important information with primary sources before any investment decision.